Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test
Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test
Cambridge Consultants adds new IP to Audio Weaver, pushes audio boundaries, brings decades of integrated systems expertise
Cambridge Consultants working in collaboration with Stratospheric Platforms Ltd unveils a wireless antenna unlike anything seen before, delivering affordable 5G connectivity from a fleet of zero-emissions aircraft.
Cambridge Consultants & Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.
Flylogix will exploit Iridium’s state-of-the-art satellite communications to enable unmanned aerial vehicles to perform remote monitoring of offshore installations.
Cambridge Consultants developed EnfuseNet, a breakthrough Artificial Intelligence (AI) system for autonomous vehicles. A low-cost system that generates high-resolution depth data for vehicle perception technology.
Cambridge Consultants today unveils Veloci-Vent, a sophisticated emergency ventilator designed and built at the request of the UK Government for use in the treatment of COVID-19.
Cambridge Consultants and a group of construction and IT companies that includes NEC have jointly developed a system to promote the use of safety harnesses, which are essential for preventing falling accidents during high rise construction.
Leading medical device development companies have been asked by the UK Government to develop and manufacture ventilators at massive speed.
Massively accelerated image processing supports development of novel treatments for neurological conditions
This Sunday more than 50 Cambridge Consultants staff will take to the streets of Cambridge in the Saucony Cambridge Half Marathon.
Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced the successful close of its Series B funding.